Skip to NavigationSkip to content

News

In a drastic bid to “streamline business, invest in new medicines and drive”, Eli Lilly has announced major staff cuts to the tune of 3,500...
Bristol-Myers Squibb has announced results from a Phase 3 trial showing that patients treated with Opdivo alongside Yervoy in patients with...
A study of ecosystem of the Niagara River has discovered that antidepressants are building up in the brains of fish. The levels found in the river...
Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous tissue in just...
The FDA has placed a partial hold on clinical trials involving Bristol-Myers Squibb’s immunotherapy treatment, Opdivo, when used in combination with...
An anti-TSLP monoclonal antibody jointly developed by Amgen and AstraZeneca has met its primary endpoint in Phase 2b trials, demonstrating a...
MSD has announced that it will acquire Rigontec, a three-year old German biotech, in a deal worth an initial €115 million and with further payments...
AstraZeneca has revealed new data supporting the long-term use and efficacy of its cardiovascular drug Brilinta (ticagrelor), showing that the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches